VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management

NCT00970892 · clinicaltrials.gov ↗

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Cardiac Thrombus
Deep Vein Thrombosis
Pulmonary Embolism
Heart Valve Replacement (Mechanical or Biological With AF)
Cardiomyopathy (Ischemic or Dilated)
Peripheral Vascular Disease

Interventions

DRUG: Warfarin dose titration

Sponsor

Ankara University